Filter
1160
Filtered Results: 1160
Text search:
pharmaceutical
manufacturers
Featured
Recommendations
112
New Publications
286
Language
Document type
No document type
510
Studies & Reports
250
Guidelines
204
Manuals
84
Strategic & Response Plan
62
Fact sheets
20
Training Material
14
Situation Updates
8
Resource Platforms
4
Brochures
3
Infographics
1
Countries / Regions
Global
56
India
44
Kenya
40
Western and Central Europe
31
Ethiopia
28
Nigeria
26
Ghana
18
South Africa
18
Sierra Leone
15
Uganda
15
Ukraine
14
Zimbabwe
14
Africa
14
Bangladesh
14
Nepal
13
Malawi
13
Philippines
13
Tanzania
13
Rwanda
12
Latin America and the Carribbean
12
Eastern Europe
12
Zambia
12
Namibia
11
South–East Asia Region
10
Eastern Europe and Central Asia
8
Eswatini/ Swaziland
8
Syria
7
Indonesia
7
Liberia
7
Myanmar / Burma
7
West and Central Africa
6
Botswana
6
Thailand
5
East and Southern Africa
5
Senegal
4
Cambodia
4
Burkina Faso
3
USA
3
Haiti
3
Asia
3
Middle East and North Africa
3
Western Pacific Region
3
Vietnam
3
Egypt
3
North Macedonia
2
Serbia
2
Lesotho
2
Benin
2
China
2
Cameroon
2
Albania
2
Laos
2
Kyrgyzstan
2
Jordan
2
Germany
2
Congo, Democratic Republic of
2
North America
2
Jamaica
2
United Kingdom
2
Lebanon
2
Russia
2
Sudan
2
Tajikistan
1
Timor Leste/ East Timor
1
Australia
1
Kazakhstan
1
Chile
1
Iran
1
Fiji
1
Uzbekistan
1
Afghanistan
1
Mongolia
1
Bulgaria
1
Guinea
1
Mozambique
1
Armenia
1
Gabon
1
Turkmenistan
1
Japan
1
Denmark
1
Maldives
1
Papua New Guinea
1
Moldova
1
Georgia
1
Mali
1
Libya
1
South Sudan
1
Iraq
1
Somalia
1
Madagascar
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
386
Clinical Guidelines
105
Public Health
68
Key Resources
59
Women & Child Health
40
Pharmacy & Technologies
36
Capacity Building
9
Toolboxes
AMR
137
Pharmacy
133
COVID-19
81
TB
56
Mental Health
55
HIV
53
NTDs
35
Rapid Response
32
Planetary Health
27
Caregiver
26
Global Health Education
25
NCDs
23
Conflict
22
Health Financing Toolbox
20
Malaria
16
2.0 Rapid Response
16
Specific Hazards
12
Ebola & Marburg
11
Polio
8
Refugee
7
Disability
7
Natural Hazards
4
Zika
2
Cholera
1
Social Ethics
1
Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduce the impact of CVD, action needs to be taken to improve prevention, diagnosis, care and management of CVD diseases. Affordable essential medicines and t...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
The objective of this book is to provide health workers with easily accessible information on important aspects of the medicines commonly used at primary care level in Zimbabwe. Medicines are a crucial part of the management of most of our patients, yet many medicines are potentially dangerous if no...
Towards ending tuberculosis and multidrug-resistant tuberculosis.
A review of available evidence (2016).
28-29 June 2016; Geneva, Switzerland
The END TB strategy.
Antimicrobial resistance (AMR) is a global public health crisis that resulted in 1.14 million deaths in 2021. According to the Institute for Health Metrics and Evaluation estimates, 96 416 of these deaths occurred in the World Health Organization (WHO) Eastern Mediterranean Region. All 22 countr...
Building laboratory testing capacity
The role of evidence in the journey towards universal health coverage is paramount. Financial risk protection monitoring, the major focus of this report, informs where the WHO African Region stands in reducing the financial hardship people face due to health expenses. This report details the status ...
The Council was established in late 2020 by Dr Tedros Adhanom
Ghebreyesus (Director-General, WHO) to provide new economic thinking – reassessing how health and wellbeing are valued, produced and distributed across the economy. An all-female group of 10 distinguished economists and area experts, t...
Malaria vaccines: the 60‑year journey of hope and final success—lessons learned and future prospects
Tropical Medicine and Health (2023) 51:29
The framework recommends expanded coverage of malaria diagnostic and treatment services, intensified vector control to drive down transmission, strengthened malaria surveillance, and increased transborder collaboration, especially in terms of efforts to control the sale and use of artemisinin monoth...
Access to safe, effective and quality-assured health products and technologies is crucial for achieving universal health coverage and primary health care goals. The continued growth of the aging population; increasing burden of noncommunicable diseases; growing burden of mental health issues; climat...
Malaria remains a significant public health concern in the SADC region, accounting for 20% of childhood deaths, as well as prompting numerous outpatient visits and hospitalisations. Around three-quarters of the population, including 35 million children under the age of five and 8.5 million pregnant ...
This document, with a focus on the built environment and health care facilities, intends to guide the audience in preparing for and responding to SARI pandemics caused by existing and novel pathogens. It provides technical guidance on designing, establishing, and managing health care facilities for ...
Building true health security in a global age. Findings and recommendations of the Global Council. In landmark findings based on two years of research and convenings around the world, the new report shows that high levels of inequality are linked to outbreaks becoming pandemics and that inequality i...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
